Title: RESEARCH COMMUNICATIONS OF THE 28th ECVIM-CA CONGRESS Document date: 2018_12_19
ID: r79h9yzz_24
Snippet: Sixteen dogs with AD were randomly divided into a treatment (amoxicillin clavulanate 12.5–25mg/kg PO q12h for 7 days) or placebo group (lactose powder q12h for 7 days). All dogs received the same standardised symptomatic therapy and diet. Severity of clinical signs based on a disease activity index was compared. Furthermore, semiquantitative measurement of amoxicillinâ€resistant E. coli in fecal samples (day 0, 6, and 30) was performed......
Document: Sixteen dogs with AD were randomly divided into a treatment (amoxicillin clavulanate 12.5–25mg/kg PO q12h for 7 days) or placebo group (lactose powder q12h for 7 days). All dogs received the same standardised symptomatic therapy and diet. Severity of clinical signs based on a disease activity index was compared. Furthermore, semiquantitative measurement of amoxicillinâ€resistant E. coli in fecal samples (day 0, 6, and 30) was performed.
Search related documents:
Co phrase search for related documents- clinical sign and symptomatic therapy: 1
- disease activity and placebo group: 1, 2, 3
- disease activity and symptomatic therapy: 1
- disease activity index and placebo group: 1
- placebo group and symptomatic therapy: 1, 2, 3, 4, 5
Co phrase search for related documents, hyperlinks ordered by date